Matches in Wikidata for { <http://www.wikidata.org/entity/Q74279508> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q74279508 description "clinical trial" @default.
- Q74279508 description "ensayu clínicu" @default.
- Q74279508 description "klinisch onderzoek" @default.
- Q74279508 description "клінічне випробування" @default.
- Q74279508 description "կլինիկական փորձարկում" @default.
- Q74279508 name "Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS." @default.
- Q74279508 name "Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS." @default.
- Q74279508 type Item @default.
- Q74279508 label "Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS." @default.
- Q74279508 label "Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS." @default.
- Q74279508 prefLabel "Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS." @default.
- Q74279508 prefLabel "Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS." @default.
- Q74279508 P1050 Q74279508-380D437E-2C0E-4F8E-A27F-9F00EC5C176E @default.
- Q74279508 P1132 Q74279508-AC1A2C75-E139-4F55-B9B5-9E87A50FE6E8 @default.
- Q74279508 P1476 Q74279508-6E5EE82E-3083-4C89-8847-EEB60EB3CC4E @default.
- Q74279508 P17 Q74279508-9CA2BA5E-073D-47C3-B0D4-A33AB38435B3 @default.
- Q74279508 P2899 Q74279508-2AD74206-09F7-41D1-A086-CCF869B43AE0 @default.
- Q74279508 P3098 Q74279508-67536526-E0AE-4193-A701-3B487D85187E @default.
- Q74279508 P31 Q74279508-69F6CD3D-8F31-4E67-8EDE-AA34C63CFF17 @default.
- Q74279508 P4844 Q74279508-1AB48AD7-D50C-434B-8963-31028522712E @default.
- Q74279508 P4844 Q74279508-EDCA3363-6EE2-405C-BF3B-34603AC50063 @default.
- Q74279508 P580 Q74279508-BE7F0E97-A02D-40F7-9E9D-AFCF14FEBDCB @default.
- Q74279508 P582 Q74279508-18296733-06B1-4385-BC30-A9271726B4F4 @default.
- Q74279508 P6099 Q74279508-15BBB216-D4B3-4F35-B28F-0B6FFFC89586 @default.
- Q74279508 P6099 Q74279508-B9775E52-B92C-4A52-BB2F-454739879D39 @default.
- Q74279508 P8363 Q74279508-B36F3B48-C35E-495A-9761-80672BFE96CB @default.
- Q74279508 P1050 Q29496 @default.
- Q74279508 P1132 "+126" @default.
- Q74279508 P1476 "A Phase 1/2, Open Label, Multicenter Trial to Assess the Safety and Efficacy of MB-102 in Patients With Relapsed or Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm, Acute Myeloid Leukemia, and High Risk Myelodysplastic Syndrome" @default.
- Q74279508 P17 Q30 @default.
- Q74279508 P2899 "+18" @default.
- Q74279508 P3098 "NCT04109482" @default.
- Q74279508 P31 Q30612 @default.
- Q74279508 P4844 Q185916 @default.
- Q74279508 P4844 Q408524 @default.
- Q74279508 P580 "2019-10-16T00:00:00Z" @default.
- Q74279508 P582 "2023-03-01T00:00:00Z" @default.
- Q74279508 P6099 Q42824440 @default.
- Q74279508 P6099 Q5452194 @default.
- Q74279508 P8363 Q78089383 @default.